Trial intelligence / Profile preview

Hyperbaric Oxygen vs. Standard Pharmaceutical Therapies for Fibromyalgia Syndrome

NCT03325959Completed

Sponsor
Shamir Medical Center
Start
Mar 2017
Primary completion
Jun 2022
Countries
1
01

Overview

Randomised, open-label trial in fibromyalgia (FM) (2 arms), sponsored by Shamir Medical Center. Primary endpoint: Visual Analogue Scale at 6 months. Started Mar 2017; status: completed.

02

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT03325959.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03325959.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call